Related Experiment Videos
Long-term outcome of weekly bisphosphonates
1Division of Bone Diseases [WHO Collaborating Center for Osteoporosis Prevention], Department of Rehabilitation and Geriatrics, University Hospital, Geneva, Switzerland. Rene.Rizzoli@medecine.unige.ch
Clinical Orthopaedics and Related Research
|February 8, 2006
Summary
Once-weekly bisphosphonates are as effective and safe as daily doses for treating osteoporosis. This dosing schedule improves convenience and may enhance patient compliance for better long-term outcomes.
Area of Science:
- Pharmacology
- Bone Metabolism
- Osteoporosis Treatment
Background:
- Bisphosphonates are the primary treatment for osteoporosis.
- Potent bisphosphonates like alendronate and risedronate reduce bone turnover and increase bone mineral density (BMD).
- These effects correlate with reduced vertebral and nonvertebral fracture risks.
Purpose of the Study:
- To evaluate the efficacy and safety of once-weekly bisphosphonate dosing compared to daily administration.
- To assess the impact of dosing frequency on patient compliance and long-term treatment success.
Main Methods:
- Therapeutic study, Level V (expert opinion).
- Analysis of clinical trial data with up to 10 years of follow-up.
- Review of pharmacokinetic and mechanism of action data.
Main Results:
- Once-weekly bisphosphonate doses demonstrate therapeutic equivalence to daily doses regarding BMD and bone remodeling markers.
- Long-term data (up to 10 years) show bisphosphonates are effective and well-tolerated.
- Safety and tolerability profiles of once-weekly doses are comparable to daily doses and placebo.
Conclusions:
- Once-weekly bisphosphonate administration is a convenient and effective alternative to daily dosing for osteoporosis.
- Improved convenience may enhance patient compliance, leading to better long-term fracture risk reduction.
- Bisphosphonates, particularly in once-weekly formulations, offer a safe and well-tolerated long-term therapeutic option for osteoporosis.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...